Healthcare ETFs Are Latest Victim to Trump

Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The healthcare sector was the worst performing area of the equities market on Wednesday, with the Health Care Select Sector SPDR (NYSEArca: XLV) down 1.3%. Meanwhile, biotech-related ETFs…Click to read more at ETFtrends.com.